Skip navigation

We are committed to helping advance COVID-19 studies quickly and effectively.COVID-19 RESOURCES & UPDATES

X
mobile search icon

News & Events

As a leader in the clinical trials community, Clinical Trials Ontario helps connect the many voices involved with clinical trials, from patients and the public to industry to scientists to research ethics boards. One way we do this is through information sharing, educational events and storytelling. See what’s new at CTO, read stories highlighting members of the clinical trials community, or view the latest news from others in our ecosystem.

Our News & Stories

Our News & Stories

Read CTO’s latest news and discover success stories and perspectives from the many voices in Ontario’s clinical trials community.

Learn More
Publications

Publications

View our annual reports, journal articles, reports and other publications here.

Learn More
CTO Conference

CTO Conference

A leading Canadian forum to drive clinical trials innovation. See why it’s a must for anyone involved in clinical trials.

Learn More
Upcoming Events

Upcoming Events

Don’t miss upcoming events from CTO and around the clinical trials community in Ontario and beyond.

Learn More
Newsletter Archive

Newsletter Archive

Read past Clinical Trials Today newsletters here and don't forget to subscribe to stay up to date!

Learn More

Our Stories

St. Michael’s researcher at the forefront of the COVID-19 global response

Dr. John Marshall is the Canadian lead investigator in the REMAP-CAP trial, and a key player in the World Health Organization (WHO) Solidarity Trial, both of which are global trials evaluating treatments for COVID-19. Planning for REMAP-CAP began in 2011.  Experience with the SARS and H1N1 convinced Dr. Marshall and his colleagues that in order to respond adequately to the next pandemic, it was necessary to have trial architecture up and running before the pandemic arrived.

Learn More
back to top